Google Gemini and Bard artificial intelligence chatbot performance in ophthalmology knowledge assessment.

ABSTRACT:

Purpose

With the popularization of ChatGPT (Open AI, San Francisco, California, United States) in recent months, understanding the potential of artificial intelligence (AI) chatbots in a medical context is important. Our study aims to evaluate Google Gemini and Bard's (Google, Mountain View, California, United States) knowledge in ophthalmology.

Methods

In this study, we evaluated Google Gemini and Bard's performance on EyeQuiz, a platform containing ophthalmology board certification examination practice questions, when used from the United States (US). Accuracy, response length, response time, and provision of explanations were evaluated. Subspecialty-specific performance was noted. A secondary analysis was conducted using Bard from Vietnam, and Gemini from Vietnam, Brazil,

SUBMITTER: Mihalache A 

PROVIDER: S-EPMC11383935 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature